Related Experiment Video

Updated: Aug 30, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Role of MRP1 in multidrug resistance in acute myeloid leukemia

O Legrand1, R Zittoun, J P Marie

  • 1EA1529, Université Paris 6, Formation de Recherche Claude Bernard, Paris, France.

Leukemia
|April 24, 1999
PubMed

Insights

Multidrug-associated protein 1 (MRP1) may contribute to chemotherapy resistance in acute myeloid leukemia (AML). Recent data clarify MRP1's role and modulation, offering insights into AML treatment resistance mechanisms.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • The MDR1 gene is a known mechanism of drug resistance in acute myeloid leukemia (AML), linked to poor patient outcomes.
  • The role of multidrug-associated protein 1 (MRP1) in anthracycline and etoposide resistance in AML has been previously unclear.

Purpose of the Study:

  • To review recent data on the functionality and modulation of MRP1 in adult AML.
  • To elucidate the role of MRP1 in comparison to other resistance mechanisms in AML.

Main Methods:

  • Literature review of recent studies on MRP1 in adult AML.
  • Analysis of data concerning MRP1 functionality and activity modulation.

Main Results:

  • Recent findings provide clarity on the functional role of MRP1 in AML.
  • Data suggest MRP1's activity can be modulated, impacting its contribution to drug resistance.

Conclusions:

  • MRP1 is an important protein to consider in the context of chemotherapy resistance in adult AML.
  • Understanding MRP1's role and modulation is crucial for developing strategies to overcome drug resistance in AML.

More Related Videos

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...